|
IMPORTANTE: Diviene
quindi INDISPENSABILE (per TUTTE le
malattie), la loro assunzione periodica, senza
dimenticare le altre tecniche naturali collaterali (alimentazione
appropriata - vedi:
Crudismo
- ed altri integratori tipo
micro
diete), riordinare
enzimi e
flora batterica
con appositi preparati (capsule) multi batterici a base
di ceppi di fermenti vivi, cioe' micro organismi
simbiotico residenti (autoctoni) non preparati su
basi derivate dal
latte:
Per l'elenco dei principali batteri utili per l'intestino, vedi:
Batteri autoctoni
Continua in:
Pag.1
Pag.2
Pag.3
Pag.4
Pag.5 Pag.7
Pag.8
Pag.9
Ricordarsi
che le alterazioni degli
enzimi, della
flora, del
pH digestivo e e
della mucosa intestinale
influenzano la salute, non soltanto a livello
intestinale, ma anche a distanza in qualsiasi parte
dell'organismo.
| BACTERIAN GROUP |
INFANT FROM
1 to 4 days |
INFANT FROM
5 to 90 days |
INFANT FROM
4 to 6 years |
ADULT FROM
20 to 40 years |
ADULT FROM
65 to 86 years |
| Total bacteria * |
10.1 |
10.5 |
10.8 |
10.8 |
10.5 |
Aerobic or
Facultative Anaerobic |
|
|
|
|
|
| Enterobacteria |
9.3 |
8.8 |
8.0 |
8.2 |
7.8 |
| Streptococcus |
8.5 |
8.1 |
7.8 |
7.7 |
8.2 |
| Lactobacillus |
6.4 |
7.3 |
7.0 |
6.7 |
8.0 |
| Staphylococcus |
6.2 |
6.8 |
4.0 |
4.4 |
4.3 |
| Yeast |
3.5 |
4.0 |
4.2 |
3.7 |
4.6 |
| Anaerobic |
|
|
|
|
|
| Bacteroides |
8.6 |
8.2 |
10.4 |
10.3 |
10.0 |
| Eubacteria |
0 |
9.7 |
9.9 |
9.9 |
9.5 |
| Bifidobacterium |
9.3 |
9.9 |
10.1 |
9.8 |
9.4 |
| Peptococcus |
0 |
9.0 |
8.1 |
8.9 |
7.7 |
| Clostidium Perfringens |
5.9 |
6.9 |
5.7 |
4.8 |
6.6 |
| Veillonella |
5.6 |
6.3 |
5.2 |
4.8 |
6.1 |
a: log cfu - Source: from Mitsuoka 1984
PROPOSED MECHANISMS OF BENEFICIAL AND
DETRIMENTAL EFFECTS OF LAB PROBIOTICS
|
RESPONSE |
PROPOSED MECHANISMS |
MAIN SITE OF ACTION |
|
Beneficial |
|
|
|
Suppression of harmful bacteria |
(1) Production of antibacterial compounds |
S, SI |
|
|
(2) Competition for nutrients |
S, SI, LI |
|
|
(3) Competition for colonization sites |
S, SI |
|
Microbial/host metabolism |
(1) Production of enzymes which support digestion
(e.g., lactase) |
S, SI |
|
|
(2) Decreased production of ammonia, amines or toxic enzymes |
SI, LI |
|
|
(3) Improved gut-wall function |
SI, LI |
|
Improved immune response of host |
(1) Increased antibody levels |
SI, (LI) |
|
|
(2) Increased macrophage activity |
SI, (LI) |
|
Detrimental |
|
|
|
Competition for nutrients with host |
(1) Consumtion of glucose |
S, SI |
|
|
(2) Consumption of amino acids |
S, SI |
S=
Stomach; SI= Small Intestine; LI= Large Intestine
Source: Data adapted according to Fuller (1989) and Impey and Mead
DIFFERENT
OLIGOSACCHARIDES, DISACCHARIDES, AND POLYOLS INFLUENCING
THE INTESTINAL MICROFLORA AND ESPECIALLY BIFIDOBACTERIA
| CARBOHYDRATE SUBSTRATE |
PROMOTED BACTERIA |
REFERENCES |
| Fructooligosaccharides |
Bifidobacteria |
Hidaka et al. (1986) |
| Transgalactosyl oligosaccharides
(TOS) |
Bifidobacteria |
Kohmoto et al. (1988) |
| 4’ Galactosyl – lactose |
Bifidobacteria |
Ohtsuka et al. (1989) |
| Isomaltooligosaccharides |
Bifidobacteria |
Homma (1988) |
| Galactooligosaccharides
(Oligomate 50) |
Bifidobacteria, lactobacilli
|
Ito et al. (1990) |
| Galactosyl – oligosaccharides |
Bifidobacteria |
Minami et al. (1983) |
| Soybean oligosaccharides |
Bifidobacteria, some lactobacilli |
Hayakawa et al. (1990)
Koboyashi et al. (1984),
Saito et al. (1992) |
| Xylooligosaccharides |
Bifidobacteria |
Okazaki et al. (1990) |
| Palatinose |
Bifidobacteria |
Kashimura et al. (1989) |
| Lactitol |
? |
Felix et
al. (1990)
Salminen and Salminen (1986) |
| Xylitol |
Lactic acid bacteria |
Salminen et al. (1985) |
| Lactulose |
Bifidobacteria and Lactic acid
|
Harju (1991)
Terada et al. (1992) |
| Inulofructisaccharides |
Bifidobacteria |
Yamazaki and Dilawri (1990) |
|
